Clinical Trials on Healthy Adult Volunteers in United States

Total 10841 results

Genentech, Inc.

Completed

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

Healthy Volunteers

United States
Vedanta Biosciences, Inc.

Completed

First-in-human Study of VE303 in Healthy Adult Volunteers

Healthy Volunteers

United States
National Institutes of Health Clinical Center (CC)

Terminated

Imaging Techniques in CT: Technical Development

Healthy Volunteers

United States
BeiGene

Completed

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males

Healthy Volunteers

United States
Celgene

Completed

Radiolabeled Study of CC-122 in Healthy Subjects

Healthy Volunteers

United States
Intra-Cellular Therapies, Inc.
Laureate Institute for Brain Research, Inc.

Completed

Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement

Healthy Volunteers

United States
Agios Pharmaceuticals, Inc.

Completed

Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants

Healthy Volunteers

United States
Concert Pharmaceuticals
Celerion

Completed

Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers

Healthy Volunteers

United States
Food and Drug Administration (FDA)
BioPharma Services, Inc

Completed

Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets

Healthy Volunteers

United States
Johns Hopkins University

Withdrawn

Behavioral and Physiological Effects of THC and CBD

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Two Dosage Forms of LY2886721 in Healthy Participants

Healthy Volunteers

United States
Takeda

Terminated

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of LY3031207 in Healthy Subjects

Healthy Volunteers

United States
USDA Beltsville Human Nutrition Research Center

Completed

Measuring Single-Serving Grain Intake

Healthy Volunteers

United States
Cyclerion Therapeutics

Completed

A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers

Healthy Volunteers

United States
University of Wisconsin, Madison

Completed

A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers (UWI-02)

Healthy Volunteers

United States
ACEA Therapeutics, Inc.

Completed

Study of AC0058TA in Healthy Male and Female Subjects

Healthy Volunteers

United States
Takeda

Completed

Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Multiple Dose Study of LY3023703 in Healthy Participants

Healthy Volunteers

United States
Pfizer

Completed

First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers

Healthy Volunteers

United States
Taisho Pharmaceutical R&D Inc.

Completed

Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers

Healthy Volunteers

United States
Cognition Therapeutics

Completed

Drug Interaction Study of CT1812 in Healthy Volunteers

Healthy Volunteers

United States
Promentis Pharmaceuticals, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023

Healthy Volunteers

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib in Healthy Female Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib (LY2484595) in Healthy Participants

Healthy Volunteers

United States
University of California, Davis

Completed

Collagen Vitamin C Dose Response Performance (Collagen)

Healthy Volunteers

United States
National Institute on Aging (NIA)

Completed

The Relationship Between Uric Acid and Inflammatory Markers

Healthy Volunteers

United States
Regeneron Pharmaceuticals

Completed

Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers

Healthy Volunteers

United States
Johns Hopkins University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers

Healthy Volunteers

United States
EtectRX, Inc.

Completed

ID-Cap System Under Direct Observation

Healthy Volunteers

United States
Metabolic Technologies Inc.
National Institute on Aging (NIA); Vanderbilt University

Completed

2-HOBA: Initial Evaluation in Humans (2-HOBA)

Healthy Volunteers

United States
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers

Healthy Volunteers

United States
ORIC Pharmaceuticals

Completed

Study of ORIC-101 in Healthy Adult Subjects

Healthy Volunteers

United States
Bristol-Myers Squibb

Completed

A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference Tablet

Healthy Volunteers

United States
Regeneron Pharmaceuticals
Department of Health and Human Services

Completed

Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers

Healthy Volunteers

United States
Bristol-Myers Squibb

Completed

An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants

Healthy Volunteers

United States
University of Pittsburgh

Withdrawn

Insulin Modulation of fMRI Connectivity in Healthy Adults

Healthy Volunteers

United States
Ablynx

Completed

Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.

Healthy Volunteers

United States
Hoffmann-La Roche

Completed

A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib

Healthy Volunteers

United States
Achaogen, Inc.

Completed

A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin

Healthy Volunteers

United States
Achaogen, Inc.
Celerion

Completed

A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin

Healthy Volunteers

United States
National Institute of Neurological Disorders and...

Withdrawn

Physiology of Volition Studied With Nerve Block

Healthy Volunteers

United States
National Institute of Neurological Disorders and...

Completed

Brain Activity in Time Discrimination and Sensory Input

Healthy Volunteers

United States
USDA Beltsville Human Nutrition Research Center

Completed

Daily Consumption of Well-Cooked Broccoli May Affect Glucosinolate Metabolites and Inflammatory Biomarkers

Healthy Volunteers

United States
Medtronic - MITG

Completed

Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable

Healthy Volunteers

United States
Takeda

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants

Healthy Volunteers

United States
University of Florida

Withdrawn

The Brain Alerting Mechanism Study

Healthy Volunteers

United States
Celltrion

Completed

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Healthy Volunteers

United States

3

Subscribe